Medscape

Baricitinib Outperforms TNF Inhibitors in Rheumatoid Arthritis, but Safety Concerns Remain

Baricitinib may be the superior choice to tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis (RA) for whom conventional synthetic disease-modifying antirheumatic drugs ...
Healio

Switching to upadacitinib superior to cycling TNF inhibitors in rheumatoid arthritis

Please provide your email address to receive an email when new articles are posted on . Switching from a TNF inhibitor to upadacitinib was superior to cycling TNF inhibitors. Upadacitinib outcomes ...
Healio

Hospitalization, mortality risks in RA-ILD similar for TNF inhibitors, non-TNF agents

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — TNF inhibitors demonstrate comparable risks for hospitalization and death vs. non-TNF agents in ...
Monthly Prescribing Reference

TNF-α Inhibitors Lower Risk for Sleep Apnea in Patients With Juvenile Idiopathic Arthritis

Patients with juvenile idiopathic arthritis treated with tumor necrosis factor-alpha inhibitors had a significantly reduced risk of developing obstructive sleep apnea, suggesting a potential benefit ...
Medscape

TNF Inhibitors Show Comparable Safety With Non-TNF Inhibitors in US Veterans With RA-ILD

Tumor necrosis factor (TNF) inhibitors led to no significant difference in survival or respiratory-related hospitalizations compared with non-TNF inhibitors, in patients with rheumatoid ...
Rheumatology Advisor

IL-17 Inhibitors Linked to Higher Persistence After TNF Inhibitor Failure in axSpA

Drug retention is similar with second-line IL-17 inhibitors vs TNF inhibitors among patients with axSpA who discontinued their initial TNF inhibitor.
MedPage Today

You Can Tell SpA Patients That TNF Inhibitors May Cut Fracture Risk

Patients with axial spondyloarthritis (axSpA) treated with tumor necrosis factor (TNF) inhibitors were at significantly lower risk for hip and spine fractures compared with those receiving only ...
The American Journal of Managed Care

Study Suggests TNF Inhibitor Use Is Cardioprotective in Radiographic Axial Spondyloarthritis

Tumor necrosis factor (TNF) inhibitor use was associated with a lower risk of cardiovascular outcomes in patients with radiographic axial spondyloarthritis in a recent study. Axial spondyloarthritis ...
Monthly Prescribing Reference

TNF Inhibitors Linked With Lower Cardiovascular Risk in Ankylosing Spondylitis

A significantly lower risk for cardiovascular events was associated with tumor necrosis factor inhibitor exposure vs nonexposure to biological disease-modifying antirheumatic drugs among patients with ...
Business Wire

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
MedPage Today

For IBD, No Cardiovascular Risk Difference Between JAK, TNF Inhibitors

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...